1997
DOI: 10.1097/00005176-199708000-00012
|View full text |Cite
|
Sign up to set email alerts
|

Use of Cisapride in Treatment of Constipation in Children

Abstract: This study did not demonstrate a clinical role for the use of cisapride in the treatment of idiopathic constipation in children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
1
1

Year Published

1998
1998
2011
2011

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 14 publications
0
16
1
1
Order By: Relevance
“…We also observed changes in the patterns of colonic dysmotility toward normal patterns or exclusive involvement of distal colonic portions (Table 3) and fecaloma emptying, neutralizing the phrenocolonic reductive effect on the proximal motility of the digestive tube. 8,11,12 Only one study analyzed orocecal transit time during treatment and did not show its reduction, 24 in opposition to our data, which showed a decrease in this parameter using both lactulose and bean test meal. It is worth mentioning that dysmotility of the proximal digestive tube may be associated with symptoms in the upper abdomen, such as early saciety, which may disappear after fecaloma emptying.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…We also observed changes in the patterns of colonic dysmotility toward normal patterns or exclusive involvement of distal colonic portions (Table 3) and fecaloma emptying, neutralizing the phrenocolonic reductive effect on the proximal motility of the digestive tube. 8,11,12 Only one study analyzed orocecal transit time during treatment and did not show its reduction, 24 in opposition to our data, which showed a decrease in this parameter using both lactulose and bean test meal. It is worth mentioning that dysmotility of the proximal digestive tube may be associated with symptoms in the upper abdomen, such as early saciety, which may disappear after fecaloma emptying.…”
Section: Discussioncontrasting
confidence: 99%
“…It is worth mentioning that dysmotility of the proximal digestive tube may be associated with symptoms in the upper abdomen, such as early saciety, which may disappear after fecaloma emptying. 6,8,10,12 Regarding total and segmental colonic transit times, it is difficult to compare our results with the few studies found in the literature, considering that distinct therapy regimens 14,16,24,25 or patients with constipation associated with neurological involvement were analyzed. 15 Regarding our patients with clinical symptoms improved upon Our data also show a higher probability of laxative need after 1 year of treatment in patients with persistence of delayed total colonic transit time at the sixth week of treatment, underscoring the importance of the initial phase of treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Tempo de trânsito e constipação -Soares AC et al Quanto ao tempo de trânsito colônico total e segmentar, é difícil a comparação de nossos resultados com os poucos estudos da literatura, considerando que foram avaliados esquemas terapêuticos diferentes 14,16,24,25 ou pacientes com constipação associada com comprometimento neurológico 15 . Em nossos pacientes com boa evolução clínica com o esquema terapêutico prescrito, é possível especular que tenha ocorrido redução das dimensões colônicas, o que poderia contribuir para a normalização de sua função peristáltica.…”
Section: Discussionunclassified
“…Initially, Staiano et al [29] showed, in 20 children randomized either to cisparide, 0.2 mg/kg three times daily, or placebo, for a 12-week period, that cisapride significantly increased stool frequency, and decreased laxative use and transit time. Later, Odeka et al [30] randomized 37 children either to cisparide, 0.2 mg/kg three times daily, or to placebo, for an 8-week period, and no significant differences were shown. Halabi [28] completed a randomized trial in which 69 patients received either cisapride at 0.3 mg/kg four times daily or placebo and found significant differences between stool frequency as well as improved gastrointestinal transit.…”
Section: Cisapridementioning
confidence: 99%
“…No differences were reported in the final numbers when comparing cisapride with placebo, most likely related to a lack of power. As can be appreciated, three groups of authors have shown cisapride to be effective [7•,28,29], whereas one did not [30]. The reason for the discrepancy is not clear, but it is possible that the dose and duration in the trial that showed no differences were suboptimal, as some patients may respond to doses of 0.3 mg/kg three times a day [7•,28].…”
Section: Cisapridementioning
confidence: 99%